Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Clinical research needs better interpretation

SABCS 2008

10 - 14 Dec 2008

Published: 12 Jan 2009

Views: 17907

Rating:

Save

Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncology

Cinical research is dangerous unless interpreted in a proper way - increased accuracy of testing biomarkers needed and increased statistical investigation

Related Videos

ctDNA positivity predicts poor response and recurrence risk in triple-negative breast cancer

Dr Priya Rastogi - NSABP Foundation & University of Pittsburgh School of Medicine, Pittsburgh, USA

ctDNA positivity predicts poor response and recurrence risk in triple-negative breast cancer ( Dr Priya Rastogi - NSABP Foundation & University of Pittsburgh School of Medicine, Pittsburgh, USA )

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer

Dr Ricardo Pinto - i3S, Porto, Portugal

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Dr Marina Garassino - University of Chicago, Chicago, USA

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC ( Dr Marina Garassino - University of Chicago, Chicago, USA )

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

ESMO 2024: Latest in EGFR mutated NSCLC

Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip

ESMO 2024: Latest in EGFR mutated NSCLC ( Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip )

Understanding the use of PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard

Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

More from ecancer